These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 18669512)
1. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R; Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512 [TBL] [Abstract][Full Text] [Related]
2. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Evans MC; Barnes J; Nielsen C; Kim LG; Clegg SL; Blair M; Leung KK; Douiri A; Boyes RG; Ourselin S; Fox NC; Eur Radiol; 2010 Mar; 20(3):674-82. PubMed ID: 19760240 [TBL] [Abstract][Full Text] [Related]
3. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176 [TBL] [Abstract][Full Text] [Related]
4. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Chou YY; Leporé N; Avedissian C; Madsen SK; Parikshak N; Hua X; Shaw LM; Trojanowski JQ; Weiner MW; Toga AW; Thompson PM; Neuroimage; 2009 Jun; 46(2):394-410. PubMed ID: 19236926 [TBL] [Abstract][Full Text] [Related]
5. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264 [TBL] [Abstract][Full Text] [Related]
6. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease. Spasov S; Passamonti L; Duggento A; Liò P; Toschi N; Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174 [TBL] [Abstract][Full Text] [Related]
7. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC; Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849 [TBL] [Abstract][Full Text] [Related]
8. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Löwe LC; Gaser C; Franke K; PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431 [TBL] [Abstract][Full Text] [Related]
9. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G; Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341 [TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM; Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105 [TBL] [Abstract][Full Text] [Related]
11. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. Shi J; Stonnington CM; Thompson PM; Chen K; Gutman B; Reschke C; Baxter LC; Reiman EM; Caselli RJ; Wang Y; Neuroimage; 2015 Jan; 104():1-20. PubMed ID: 25285374 [TBL] [Abstract][Full Text] [Related]
12. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome. Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720 [TBL] [Abstract][Full Text] [Related]
13. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN; Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760 [TBL] [Abstract][Full Text] [Related]
14. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM; Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658 [TBL] [Abstract][Full Text] [Related]
15. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. Dukart J; Sambataro F; Bertolino A J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054 [TBL] [Abstract][Full Text] [Related]
16. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid. Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies. Podhorna J; Krahnke T; Shear M; Harrison JE; Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820 [TBL] [Abstract][Full Text] [Related]
18. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353 [TBL] [Abstract][Full Text] [Related]
20. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study. Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]